A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This study is being carried out to investigate if AZD5672 is effective in treating Rheumatoid
Arthritis (RA) and if so how it compares to placebo (a substance which does not have any
action) and etanercept (a medicine already available to treat Rheumatoid Arthritis) when
added to treatment with methotrexate. The purpose of this study is also to find out which
dose of AZD5672 is the most effective at treating RA and to find out how well the body
tolerates AZD5672 when taken for up to 12 weeks.